Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - amifostine, quantity: 500 mg - injection, powder for - excipient ingredients: - to decrease the incidence of neutropenia related fever and infection induced by dna-binding chemotherapeutic agents (classical alkylating agents such as cyclophosphamide and non-classical alkylating agents such as mitomycin-c and platinum-containing drugs); decrease in the incidence of acute and cumulative nephrotoxicity associated with platinum-based therapy; and the provision of better adherence to these types of chemotherapy regimens. indications as at 31 march 2000: ethyol is indicated to decrease the incidence of neutropenia-related fever and infection induced by dna-binding chemotherapeutic agents (classical alkylating agents such as cyclophosphamide and non-classical alkylating agents such as mitomycin-c and platinum containing drugs); decrease the incidence of acute and cumulative nephrotoxicity associated with platinum-based therapy; and to provide better adherence to these types of chemotherapy regimens. ethyol is also indicated to protect against acute and late xerostomia associated with standard fractionated radiation therapy in patients with head and neck cancer.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - chloramphenicol sodium succinate (equivalent: chloramphenicol, qty 1 g) - injection, powder for - excipient ingredients: - chloromycetin succinate is specifically indicated for bacterial meningitis, typhoid fever, rickettsial infections, intra ocular infections, other serious infections where bacteriological evidence or clinical judgement indicates that chloramphenicol is appropriate antibiotic.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - foscarnet sodium, quantity: 24 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid - treatment of cytomegalovirus (cmv) retinitis in patients with the acquired immunodeficiency syndrome (aids). indications as at 11 november 1994: for treatment of cytomegalovirus (cmv) retinitis in patients with acquired immunodeficiency syndrome (aids); and treatment of aciclovir resistant herpes simplex virus (hsv) infections (defined by clinical trial or in-vitro resistance) in immunocompromised patients with human immunodeficiency virus (hiv) infection. note: the indication for treatment of aciclovir resistant hsv infections in immunocompromised patients with hiv infections is based primarily on the results of one open label comparative study. this was of patients with hiv infections and herpetic lesions unresponsive to aciclovir administered intravenously for 10 days or more and in-vitro documented resistance to aciclovir. eight patients were randomised to foscarnet (40mg/kg iv given eight hourly) and 6 were randomised to vidarabine 15mg/kg iv daily. the results showed a significant difference in favour o

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - colistimethate sodium (equivalent: colistin, qty iu) - injection, powder for - excipient ingredients: - colistin link parental is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli. it is particularly indicated when the infection is caused by sensitve strains of pseudomonas aeruginosa. this antibiotic is not indicated for infections due to proteus and neisseria. colistin link parental has proven clinically effective in treatment of infections due to the following gram-negative organisms: enterobacter aerogenes, escherichia coli, klebsiella pneumoniae and pseudomonas aeruginosa. pending results of appropriate bacterialogic cultures and sensitvity tests, colistin link parental may be used to initiate therapy in serious infections that are suspected due to gram-negative organisms.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - interferon gamma-1b, quantity: 4 million iu/ml - injection, solution - excipient ingredients: succinic acid; sodium succinate hexahydrate; mannitol; water for injections; polysorbate 20 - as an adjunct for reduction of the frequency of serious infections in patients with chronic granulomatous disease (cgd). the benefits of imukin have been most marked in children with cgd although imukin may be used in adult patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - erythromycin lactobionate, quantity: 1.4882 g/g (equivalent: erythromycin, qty 1 g) - injection, powder for - excipient ingredients: - oral erythromycin is not considered to be the antibiotic of choice in severely ill patients.,erythromycin-link (sterile erythromycin lactobionate) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below when oral administration is not possible or when the severity of the infection requires immediate high serum levels of erythromycin. intravenous therapy should be replaced by oral administration at the appropriate time.,? upper respiratory tract infections caused by streptococcus pyogenes (group a beta-haemolytic streptococci); streptococcus pneumoniae (diplococcus pneumoniae); haemophilus influenzae (many strains of h. influenzae are not susceptible to the erythromycin concentrations ordinarily achieved).,? lower respiratory tract infections caused by streptococcus pyogenes (group a beta-haemolytic streptococci); streptococcus pneumoniae (diplococcus pneumoniae).,? respiratory tract infections due to mycoplasma pneumoniae.,? skin and s

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - mercaptopurine monohydrate, quantity: 50 mg - tablet - excipient ingredients: pregelatinised maize starch; stearic acid; maize starch; magnesium stearate; lactose - treatment of acute leukaemia. it is of value in remission induction and is particularly indicated for maintenance therapy in acute lymphoblastic leukaemia and acute myelogenous leukaemia.,mercaptopurine-link is also used in the treatment of chronic granulocytic leukaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

australian by nature pty ltd - propolis resin, quantity: 100 mg/ml (equivalent: propolis, qty 200 mg/ml; equivalent: lead, qty 100 ng/ml) - liquid, multipurpose - excipient ingredients: propylene glycol; eucalyptus oil; spearmint oil - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; traditionally used in naturopathic medicine to soothe/relieve mouth/oral irritation ; traditionally used in naturopathic medicine to decrease/reduce/relieve symptoms of mild mouth ulcers ; maintain/support immune system health ; maintain/support healthy immune system function ; traditionally used in naturopathic medicine to soothe/relieve skin inflammation ; traditionally used in naturopathic medicine to antimicrobial for minor cuts and abrasions

Australia - English - Department of Health (Therapeutic Goods Administration)

australian orthopaedic fixations pty ltd - 44054 - surgical procedure kit, orthopaedic, reusable - a procedure pack is a set of orthopaedic instruments located within specially designed instrument trays (procedure packs) that are used to facilitate and assist surgeons in the implantation of medical devices during orthopaedic surgery. an orthopaedic manual surgical instrument is a hand-held device intended for medical purposes to manipulate tissue, assist in inserting the associated implantable device, or guide other instruments such as drills and pins. this generic type of device includes non-sterile devices that are located in instrument trays that consist of instruments including nail holders, awl, retractor, forceps, tissue guard, drill sleeves, screwdrivers and alignment guides .

Australia - English - Department of Health (Therapeutic Goods Administration)

australian precision instruments pty ltd -